700 arthritis patients to reveal Real-World drug performance
Knowledge-focused
Recruiting now
This study follows 700 adults with axial spondyloarthritis or psoriatic arthritis who have just started a new medication (bimekizumab, upadacitinib, risankizumab, guselkumab, or a TNF inhibitor) at UK hospitals. Researchers will review medical records and ask patients to complete…
Sponsor: Adelphi Real World • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC